Team:TU Delft-Leiden/Project/Life science/EET/cloning
From 2014.igem.org
Line 54: | Line 54: | ||
<h4> Cloning Scheme </h4> | <h4> Cloning Scheme </h4> | ||
<p> | <p> | ||
- | Making a BioBrick of the <i>mtrCAB</i> operon is quite challenging. First of all, the coding sequence of <i>mtrCAB</i> contains several illegal restrictions sites. Secondly, we need to have the operon under the regulation of an | + | Making a BioBrick of the <i>mtrCAB</i> operon is quite challenging. First of all, the coding sequence of <i>mtrCAB</i> contains several illegal restrictions sites. Secondly, we need to have the operon under the regulation of an weakened T7 lacO promoter, which was found to be the best promoter to express <i>mtrCAB</i> in <i> E. coli </i> [1]. To get rid of the illegal restriction sites as well as implementing the T7 lacO promoter in our BioBrick <a href="http://parts.igem.org/Part:BBa_K1316012">BBa_K1316012 </a> , we ended up having 5 pieces of DNA to be ligated into pSB1C3. To work efficiently, we used the <a href="https://2012.igem.org/Team:Freiburg/Project/Golden#GGC">Golden Gate Assembly </a> to clone <a href="http://parts.igem.org/Part:BBa_K1316012">BBa_K1316012 </a> (see figure 3). |
</p> | </p> | ||
Revision as of 14:50, 17 October 2014
Module Electron Transport – Cloning
In the wet lab, we integrated the Electron Transport pathway of Shewanella oneidensis into Escherichia coli. Here you can find information with respect to cloning of the BioBricks for the Electron Transport pathway.
mtrCAB and mtrCAB-HIS
Our BioBricks BBa_K1316012 and BBa_K1316017 encode the mtrCAB genes under control of an weakened T7 promoter with the lac operator (T7 lacO). In addtion, BBa_K1316017 carries a histidine (HIS) tag at the 5' end of the coding sequnece, which makes it easier to purify MtrC during characterization experiments. The end constructs are visualized in figure 1 and 2.
Cloning Scheme
Making a BioBrick of the mtrCAB operon is quite challenging. First of all, the coding sequence of mtrCAB contains several illegal restrictions sites. Secondly, we need to have the operon under the regulation of an weakened T7 lacO promoter, which was found to be the best promoter to express mtrCAB in E. coli [1]. To get rid of the illegal restriction sites as well as implementing the T7 lacO promoter in our BioBrick BBa_K1316012 , we ended up having 5 pieces of DNA to be ligated into pSB1C3. To work efficiently, we used the Golden Gate Assembly to clone BBa_K1316012 (see figure 3).
To generate BBa_K1316017 (construct with mtrCAB-HIS), the last reverse primer was designed in a way that a 6 x His tag was introduced at the C-terminus of the MtrB protein. This tag aims to be able to easily detect and purify this protein.
The Golden Gate primers were designed so that, due to the used BsaI enzyme, at the end of this assembly the 5' end of the assembled construct was compatible with a fragment restricted with EcoRI and the 3' end with a fragment restricted with SpeI. Consequently, the Assembled fragment was compatible with an iGEM backbone restricted with the enzymes EcoRI and SpeI. This way, the assembled construct was introduced into the pSB1C3 iGEM backbone.
Later on, the mtrCAB BioBricks (BBa_K1316012 and BBa_K1316017) were introduced into pSB3K3, because it is a backbone with a much lower copy number than pSB1C3, and in the literature the mtrCAB genes were found to be quite toxic for E. coli.
ccmAH
Final constructs
The BioBrick constructed using the ccmAH gene cluster is BBa_K1316011 (figure 4).
Cloning Scheme
The BioBrick BBa_K1316011 was built up by amplifying the best performing promoter according to Goldbeck [1] and introducing it upstream the coding region of the ccmAH cluster of the Biobrick BBa_K917006 constructed by the iGEM team Edinburgh 2012, which was already BioBrick compatible.
A more graphical representation of the cloning strategy can be found on figure 5.
References
[1] C.P. Goldbeck, H.M. Jensen et al., “Tuning Promoter Strengths for Improved Synthesis and Function of Electron Conduits in Escherichia coli”, ACS Synth. Biol. 2, 150-159, 2013.